Skip to main content

Rapid Quantification of Neurons and Stem/Progenitor Cells in the Adult Mouse Brain by Flow Cytometry

Buy Article:

$63.00 + tax (Refund Policy)

In order to develop novel therapies for the treatment of central nervous system diseases, methods for rapid quantification of different neural cell populations, from healthy or diseased brains, are highly desirable. Today, the method of choice to quantify different cell populations in the brain is immunohistochemistry. This technique is precise and reliable, but is also very time consuming and cost-intensive. In this paper, we describe a rapid procedure where neurons and neural stem/progenitor cells from the adult mouse are isolated, immediately fixed, and quantified with different cell type specific markers by flow cytometry.

Our results show that we can reproducibly detect and quantify mature neurons with antibodies towards microtubuli associated protein (MAP2) and neuronal nuclei (NeuN), both in hippocampus and olfactory bulb. Stem/progenitor cell detection and quantification were achieved using antibodies specific for bromodeoxyuridine (BrdU) and doublecortin (DCX). The flow cytometric analysis revealed fractions of positive cells corresponding to the in vivo situation, confirmed and validated by traditional immunohistochemistry and stereological counting procedures.

We conclude that the flow cytometric technique can be used as a rapid screening method to accurately quantify neuronal populations and to detect and quantify other brain cell types, such as neural stem/progenitor cells.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Flow cytometry; Hippocampus; Neurogenesis; Neurons; Olfactory bulb; Rapid quantification; Stem/progenitor cells

Document Type: Research Article

Publication date: 01 December 2007

More about this publication?
  • Letters in Drug Design & Discovery publishes original letters on all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis will be on publishing quality papers very rapidly. Letters will be processed rapidly by taking full advantage of Internet technology for both the submission and review of manuscripts. The journal is essential reading to all pharmaceutical scientists involved in research in drug design and discovery.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more